Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Hanish Sampath Kumar

Geriatric Medicine Saint Louis, MO Medical Doctor

NPI 1386030252 CMS profile 7826312

1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110

Open in the dashboard

General payments

$1,586

27 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hanish Sampath Kumar of Saint Louis, MO is reported in the CMS Open Payments database as having received $1,586 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Geriatric Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $963 13
2024 General $203 6
2023 General $76 3
2022 General $343 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hanish Sampath Kumar
  • Geriatric Medicine median
  • Middle half of Geriatric Medicine
  • National median

In program year 2025, general payments to Hanish Sampath Kumar were reported at $963. Among 1,028 Geriatric Medicine profiles paid that year, the median was $123 and the middle half received between $35 and $408.

Show as a table
Year Hanish Sampath Kumar Geriatric Medicine median Middle half National median
2019 $0 $122 $40–$435 $163
2020 $0 $98 $25–$349 $114
2021 $0 $125 $34–$441 $132
2022 $343 $124 $36–$408 $149
2023 $76 $121 $41–$383 $160
2024 $203 $134 $41–$435 $164
2025 $963 $123 $35–$408 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Abiomed $822 7 payments
  2. Merck Sharp & Dohme Corporation $179 7 payments
  3. Edwards Lifesciences Corporation $160 2 payments
  4. Abbott Laboratories $158 2 payments
  5. AbbVie, Inc. $135 6 payments
  6. Daxor Corporation $106 2 payments
  7. Becton, Dickinson and Company $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,202 26 payments
  2. Travel and Lodging $384 1 payment
Products named General payments · program years 2022–2025
  1. HemoSphere $185 3 payments
  2. ZERBAXA $179 7 payments
  3. ENSITE PRECISION $158 2 payments
  4. AVYCAZ $135 6 payments
  5. BVA-100 $106 2 payments
  6. RECARBRIO $102 4 payments
  7. TEFLARO $64 3 payments
  8. EMBLAVEO $19 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$62,384

Medicare's payments for the services billed

Medicare patients

162

Average age 72

Services billed

541

69 women, 93 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 65%
Ischemic heart disease 62%
Diabetes 59%
COPD 59%
Arthritis 59%
Chronic kidney disease 56%
Atrial fibrillation 55%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
AVYCAZ
  • AbbVie, Inc. $37
$37 — —
ZERBAXA
  • Merck Sharp & Dohme Corporation $37
$37 — —
RECARBRIO
  • Merck Sharp & Dohme Corporation $37
$37 — —
TEFLARO
  • AbbVie, Inc. $13
$13 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Geriatric Medicine in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record